Copenhagen, 2015-02-24 13:09 CET (GLOBE NEWSWIRE) -- Exiqon calls for ordinary general meeting
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) calls for the ordinary general meeting to be held on Thursday 19 March 2015 at 3 pm (CET) at the company’s address, Skelstedet 16, 2950 Vedbaek, Denmark. A copy of the notice with the complete proposals is attached hereto and can also be seen at http://www.exiqon.com/investor/
Additional information
Lars Kongsbak, CEO, phone +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, phone +45 4566 0888 (cell: +45 4090 2131)
About Exiqon
Exiqon operates in two business areas: Exiqon Life Sciences is a leading provider of flexible solutions for RNA analysis used by academia, biotech and pharmaceutical companies around the world to make ground breaking discoveries about the correlation between gene activity and the development of cancer and other diseases. Exiqon Diagnostics develops novel molecular diagnostic tests for early detection of cancer and treatment selection for patients based on gene activity analysis, using the tools developed by Exiqon Life Sciences. Exiqon is listed on the NASDAQ in Copenhagen. For more information about us, please visit www.exiqon.com
